These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2964020)

  • 21. Prenatal diagnosis of thyroid hormone resistance.
    Asteria C; Rajanayagam O; Collingwood TN; Persani L; Romoli R; Mannavola D; Zamperini P; Buzi F; Ciralli F; Chatterjee VK; Beck-Peccoz P
    J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The thyrotropic function of the hypophysis and peripheral thyroid hormones after removal of bland and autonomous nodular goiters].
    Heberling HJ; Heintze M; Kuhlmann E; Lohmann D; Hartig W; Mättig H
    Dtsch Med Wochenschr; 1984 Nov; 109(46):1757-60. PubMed ID: 6499674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long term follow up of medical treatment of differentiated thyroid cancer].
    Jaffiol C; Daures JP; Nsakala N; Guerenova J; Baldet L; Pujol P; Vannereau D; Bringer J
    Ann Endocrinol (Paris); 1995; 56(2):119-26. PubMed ID: 7755338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Triiodothyroacetic acid in euthyroid goiter. New data on its mechanisms of action. Comparison with L-thyroxin].
    Pisarev MA; Brenta G; Schnitman M; Kleiman de Pisarev DL
    Bull Acad Natl Med; 2007 Nov; 191(8):1705-15; discussion 1715. PubMed ID: 18666468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor affinity and biological potency of thyroid hormones in thyrotropic cells.
    Gershengorn MC; Geras E; Marcus-Samuels BE; Rebecchi MJ
    Am J Physiol; 1979 Aug; 237(2):E142-6. PubMed ID: 223453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of 3,5,3'-triiodothyroacetic Acid and triiodothyronine on goiter prevention and involution and on hepatic and skeletal parameters in rats.
    Alvarez L; Burgueño A; Zeni S; Randi AS; Hernández S; Hockl P; Pisarev MA; Kleiman de Pisarev DL
    Horm Metab Res; 2004 May; 36(5):291-7. PubMed ID: 15156408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic applications of thyroid hormone analogues.
    Visser WE
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):170-172. PubMed ID: 32197712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Principles of thyroid hormone treatment (author's transl)].
    Pfannenstiel P
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):961-6. PubMed ID: 6775193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
    Dulgeroff AJ; Geffner ME; Koyal SN; Wong M; Hershman JM
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat.
    García MD; Escobar del Rey F; Morreale de Escobar G
    Endocrinology; 1976 Jan; 98(1):203-13. PubMed ID: 813987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of inappropriate TSH secretion with Triac].
    Lind P; Eber O
    Acta Med Austriaca; 1986; 13(1):13-6. PubMed ID: 3766083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organ-specific effects of tiratricol: a thyroid hormone analog with hepatic, not pituitary, superagonist effects.
    Sherman SI; Ladenson PW
    J Clin Endocrinol Metab; 1992 Sep; 75(3):901-5. PubMed ID: 1517383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug treatment in thyroid disease.
    Mills LC
    Semin Drug Treat; 1974; 3(4):377-402. PubMed ID: 4132535
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer.
    Regalbuto C; Maiorana R; Alagona C; Paola RD; Cianci M; Alagona G; Sapienza S; Squatrito S; Pezzino V
    Thyroid; 2007 Apr; 17(4):323-31. PubMed ID: 17465862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthyroidism due to inappropriate secretion of thyroid-stimulating hormone: diagnosis and management.
    Hermus A; Ross H; van Liessum P; Naber A; Smals A; Kloppenborg P
    Neth J Med; 1991 Jun; 38(5-6):193-8. PubMed ID: 1922591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiphasic thyrotropin responses to thyroid hormone administration in man.
    Spencer CA; LoPresti JS; Nicoloff JT; Dlott R; Schwarzbein D
    J Clin Endocrinol Metab; 1995 Mar; 80(3):854-9. PubMed ID: 7883842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triiodothyroacetic Acid Cross-Reacts With Measurement of Triiodothyronine (T3) on Various Immunoassay Platforms.
    Chan SL; Refetoff S; Babic N; Jin M; Garg U; Yeo KJ
    Am J Clin Pathol; 2022 Feb; 157(2):156-158. PubMed ID: 34542585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypothyroidism of central origin corrected by the cessation of Triac therapy].
    Heim J
    Ann Med Interne (Paris); 1982; 133(8):588-9. PubMed ID: 7171187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.